 AUSTIN, Texas--BUSINESS WIRE--TFF Pharmaceuticals, Inc. NASDAQ: TFFP, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing TFF technology platform, will participate in the 2021 BIO CEO Investor Digital Conference, being held virtually on February 16-18, 2021. Glenn Mattes, President CEO of TFF Pharmaceuticals, is scheduled to give a pre-recorded company presentation at the confere 